Centroid Consolidated Mines Changes Name to eGene Inc. -OTCBB: EGEI-.ORANGE, Calif. -- eGene Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : EGEI) is the result of a merger, effective in the State of California on July 14, 2004, between Centroid centroid In geometry, the centre of mass of a two-dimensional figure or three-dimensional solid. Thus the centroid of a two-dimensional figure represents the point at which it could be balanced if it were cut out of, for example, sheet metal. Consolidated Mines Co. (OTCBB: CCMC CCMC Commission for Case Manager Certification CCMC Communications Consortium Media Center CCMC Certified Career Management Coach CCMC Community Coordinated Modeling Center (NASA) ), which was a publicly-held company, and BioCal Technology Inc., (www.biocal.com), which was a privately-held entity. The two companies adjusted outstanding shares, options and warrants on a 1:3 basis. Intellectual properties, technologies and personnel resources were then combined to create a leading-edge biotechnology company with ready products believed to have immediate commercial relevance. "We believe our new name better reflects the strength of our technology and application platforms," said Udo Henseler, eGene's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Since we have made important progress in our product development programs in genotyping systems and in early market introductions, we feel that our new identity emphasizes our future vision." eGene Inc., a Nevada corporation A Nevada Corporation is a corporation chartered under the laws of the U.S. state of Nevada. Nevada, like the state of Delaware (See Delaware corporation), is well known as a corporate haven. , is an emerging biotech company, competing in the biological/microbial materials and life sciences testing industries. It uses its core technologies of capillary electrophoresis, microfluidics, liquid handling and automation, to create low-cost, leading-edge and novel Genotyping DNA testing DNA testing Analysis of DNA (the genetic component of cells) in order to determine changes in genes that may indicate a specific disorder. Mentioned in: Acoustic Neuroma, Retinoblastoma, Von Willebrand Disease tools for the biological/microbial materials and life sciences testing industries. eGene's strategy is to deliver applications and tools to these industries that it believes will have immediate commercial relevance. Its DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. HDA-GT12 system detects, quantifies, identifies and characterizes biological organisms, and automates routine and non-routine laboratory and industrial procedures critical to productivity. The statements included in this press release concerning predictions of performance and management's plans and objectives constitute forward-looking statements made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors which could cause or contribute to such differences include, but are not limited to, factors detailed in the Securities and Exchange Commission filings of eGene Inc. The forward-looking statements contained in this press release speak only as of the date hereof and eGene disclaims any intent or obligation to update these forward-looking statements. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion